REPORT ID 16173

Global Contraceptive Drugs Market Research Report 2017

Publish Date
02-Oct-17
Pages
110
Format
Electronic (PDF)

In this report, the global Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Contraceptive Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Contraceptive Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Cipla
    Bayer
    Merck
    Teva Pharmaceutical
    Allergan
    Pfizer
    Reckitt Benckiser
    Mankind Pharma
    Janssen Pharmaceutical
    HLL Lifecare
    Mithra Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral Contraceptives
    Contraceptive Injectable
    Topical Contraceptive Patch
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Contraceptive Drugs for each application, including
    Hospital Pharmacy
    Independent Pharmacy
    Online Platform
    Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Contraceptive Drugs Market Research Report 2017
1 Contraceptive Drugs Market Overview
    1.1 Product Overview and Scope of Contraceptive Drugs
    1.2 Contraceptive Drugs Segment by Type (Product Category)
        1.2.1 Global Contraceptive Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Contraceptive Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Oral Contraceptives
        1.2.4 Contraceptive Injectable
        1.2.5 Topical Contraceptive Patch
    1.3 Global Contraceptive Drugs Segment by Application
        1.3.1 Contraceptive Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital Pharmacy
        1.3.3 Independent Pharmacy
        1.3.4 Online Platform
        1.3.5 Clinics
    1.4 Global Contraceptive Drugs Market by Region (2012-2022)
        1.4.1 Global Contraceptive Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Contraceptive Drugs (2012-2022)
        1.5.1 Global Contraceptive Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Contraceptive Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Contraceptive Drugs Market Competition by Manufacturers
    2.1 Global Contraceptive Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Contraceptive Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Contraceptive Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Contraceptive Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Contraceptive Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Contraceptive Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Contraceptive Drugs Market Competitive Situation and Trends
        2.5.1 Contraceptive Drugs Market Concentration Rate
        2.5.2 Contraceptive Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Contraceptive Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Contraceptive Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Contraceptive Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Contraceptive Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Contraceptive Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Contraceptive Drugs Consumption by Region (2012-2017)
    4.2 North America Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Contraceptive Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Contraceptive Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Contraceptive Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Contraceptive Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Contraceptive Drugs Price by Type (2012-2017)
    5.4 Global Contraceptive Drugs Production Growth by Type (2012-2017)

6 Global Contraceptive Drugs Market Analysis by Application
    6.1 Global Contraceptive Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Contraceptive Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Contraceptive Drugs Manufacturers Profiles/Analysis
    7.1 Cipla
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Contraceptive Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Cipla Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bayer
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Contraceptive Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Merck
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Contraceptive Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Merck Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Teva Pharmaceutical
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Contraceptive Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Teva Pharmaceutical Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Allergan
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Contraceptive Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Allergan Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Contraceptive Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Reckitt Benckiser
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Contraceptive Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Reckitt Benckiser Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Mankind Pharma
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Contraceptive Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Mankind Pharma Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Janssen Pharmaceutical
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Contraceptive Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Janssen Pharmaceutical Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 HLL Lifecare
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Contraceptive Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 HLL Lifecare Contraceptive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Mithra Pharmaceuticals

8 Contraceptive Drugs Manufacturing Cost Analysis
    8.1 Contraceptive Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Contraceptive Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Contraceptive Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Contraceptive Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Contraceptive Drugs Market Forecast (2017-2022)
    12.1 Global Contraceptive Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Contraceptive Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Contraceptive Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Contraceptive Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Contraceptive Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Contraceptive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Contraceptive Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Contraceptive Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer